This article was exclusively written for European Sting by Mr. Isaac Aidoo Erzuah, a third-year medical student and research assistant at the University of Cape Coast in Ghana. He is affiliated with the International Federation of Medical Students Associations (IFMSA), cordial partner of The Sting. The opinions expressed in this piece belong strictly to the writer and do not necessarily reflect IFMSA’s view on the topic, nor The European Sting’s one.
Have you ever wondered what antibiotic resistance really means to our world? Imagine this: a tiny microbial version of cancer. Not because bacteria suddenly start behaving like rogue tumour cells, but have managed to escape the security checkpoints that have been put in place.
Antibiotic resistance begins when the systems meant to keep things under control start to crumble. In a healthy human body, cells follow rules. They listen to growth signals, respect boundaries and when they sense something is wrong, they bow out gracefully. This orderly behaviour is policed by guardians like p53 and retinoblastoma protein(Rb) that helps keep the cell cycle in check. However, when these safeguards fail, the result is cancer (growth without brakes, danger without boundaries).
Antibiotic resistance plays out in a similar way, but on the microbial stage. For decades, antibiotic drugs acted as our own medical “checkpoints”, keeping bacterial infections in line. Now, those bacteria are learning to slip past the barriers we depend on. They swap resistance genes like trading cards, mutate with astonishing speed, and evolve into versions that no longer respond to treatment. When they grow beyond our control, the impact spreads everywhere across humans, livestock, wildlife, rivers, soil, and the food systems that link us all.
The World Health Organization now ranks antimicrobial resistance (AMR) among the top ten global health threats. It hits hardest where health systems are weakest, diagnostics are scarce, sanitation is fragile and access to effective antibiotics is limited. The effects are like a global pandemic where no country, whether rich or poor, is immune.
More countries are reporting antimicrobial resistance. Resistance to ciprofloxacin in Shigella spp., for example, has shot up with a median annual increase of 27% since 2018. Carbapenem resistance in Klebsiella pneumoniae and E. coli once rare, now worryingly common. These are not just statistics but warning lights on the dashboard of global health.
This is where the One Health approach stops being a buzzword and starts being the backbone of our response. It demands cleaner water systems, stronger sanitation, better infection control, widespread vaccination, smarter antibiotic use in both humans and animals and laboratory systems that can detect resistance before it spirals. It also needs political courage: long-term investment, universal health coverage, resilient health services, and fair access to life-saving drugs.
Antibiotic resistance isn’t just a medical challenge; it’s a societal one. It blurs the lines between human health, animal health, and environmental health because, in truth, those boundaries were never separate to begin with. The fight is shared, and the clock is ticking. If we act decisively now, we can prevent AMR from becoming the next “cancer” of global health. The window is narrowing, but the future is ours to shape.
About the author
Isaac Aidoo Erzuah is a third-year medical student and research assistant at the University of Cape Coast in Ghana. He is passionate about research and has co-authored studies in public health. His research interests span public health, oncology, and genetics. Isaac holds a Bachelor’s Degree in Nursing and has been recognized for outstanding academic achievement, earning the Dean’s Award, the Head of Department Award for Best Nursing Student, and the title of Valedictorian for the School of Nursing and Midwifery in 2023. He remains dedicated to evidence-based practice and compassionate patient care.
Why don't you drop your comment here?